Natural killer (NK) cells, a type of immune cell, are critical for preventing an immune response against an infecting virus…
Articles by Marisa Wexler, MS
The molecular process that brings vitamin B12 into the brain can also transport Gilenya (fingolimod), an approved treatment for…
A novel compound that can lessen toxic overactivation of nerve cells was found to significantly reduce disease activity and restore…
Elderly adults with multiple sclerosis (MS) who adhere more to a Mediterranean diet tend to have less severe disability…
The Phase 3 EVOLUTION clinical trials have failed to demonstrate that evobrutinib is more effective than the approved medication…
Treatment with essential oils derived from green tea or pumpkin reduced brain damage in a rat model of multiple…
A new clinical trial in Australia, called PLATYPUS, will simultaneously test two medications that have already been approved for…
A novel therapy in which neural stem cells are injected into the brain was well tolerated by 15 people with…
People with multiple sclerosis (MS) who discontinue a disease-modifying treatment are more likely to have greater long-term disability…
Pixyl.Neuro, a next-generation software that uses artificial intelligence (AI) in analyzing MRI scans to help detect and monitor…
Infection with a herpes virus known as HHV-6A is associated with significantly higher levels of the nerve damage biomarker neurofilament…
Levels of proteins in the liquid that surrounds the brain and spinal cord, called the cerebrospinal fluid (CSF), can help…
ATA188, an experimental cell therapy targeting the Epstein-Barr virus, failed to outperform a placebo at easing disability levels in…
The use of a computer-based program called BrainHQ led to significantly improved scores on cognitive tests among people with…
Elevated blood levels of neurofilament light chain (NfL), an established biomarker of nerve damage, are associated with a higher risk…
Blocking the activity of a protein complex called the NLRP3 inflammasome lessened disease severity in a mouse model of…
An artificial intelligence (AI) program, called iQ-MS, outperforms traditional radiologist-based measures at quantifying changes in lesions over time in people…
Chronic pain can make it harder for people with multiple sclerosis (MS) to be physically active, but some types…
Targeting genes that control the daily activity cycle of cells that are responsible for repairing myelin in the brain and…
People with multiple sclerosis (MS) of African descent had higher levels of inflammatory B-cells in the fluid around the…
More activity among certain immune cells, as well as differences in immune signaling molecules, iron regulation, and fat metabolism, may…
People with a higher genetic risk for multiple sclerosis (MS) were seen to have detectable differences in their gut…
Achieving NEDA — no evidence of disease activity — after two years of treatment was not common among people with…
The overall financial impact of changes in treatment and delayed diagnoses for people with multiple sclerosis (MS) in Canada…
Brain atrophy (shrinkage) in people with multiple sclerosis (MS) begins on average more than five years before disease…
Six months of treatment with foralumab, administered into the nose, led to decreases in microglial activity in five of six…
New research by scientists in Austria may shed light on the link between the Epstein-Barr virus (EBV) and multiple sclerosis…
Blood levels of neurofilament light chain (NfL), a marker of nerve damage, were seen to increase about a year or…
Use of high-efficacy therapies can lower the risk of disability progression in people with childhood-onset multiple sclerosis (MS), particularly…
Treatment with the investigational therapy fenebrutinib significantly reduced the number of new inflammatory lesions visible on MRI scans in…